Equity Investment

3 Months Ended

Mar. 31, 2019

Equity Method Investment, Summarized Financial Information [Abstract]

As of both March 31, 2019 and December 31, 2018, the Company owned a 43.6% non-controlling interest in Matrix. Pursuant to a shareholder’s agreement, affiliates of Frazier Healthcare Partners hold rights necessary to control the fundamental operations of Matrix. The Company accounts for this investment in Matrix under the equity method of accounting with the Company’s share of Matrix’s income or losses recorded as “Equity in net loss of investee” in the accompanying condensed consolidated statements of operations.

The carrying amount of the assets included in the Company’s condensed consolidated balance sheets and the maximum loss exposure related to the Company’s interest in Matrix as of March 31, 2019 and December 31, 2018 totaled $159,546 and $161,503, respectively.

Summary financial information for Matrix on a standalone basis is as follows:



	March 31, 2019		December 31, 2018
Current assets	$	61,283	$	61,565
Long-term assets	712,353		719,450
Current liabilities	25,006		27,619
Long-term liabilities	372,225		373,159



	Three months ended March 31, 2019			Three months ended March 31, 2018
Revenue	$	66,983		$	67,429
Operating income (loss)	555			(789		)
Net loss	(4,486		)	(8,518		)